2020 has been a challenging time for many businesses, not least those who still need to operate safely during the Covid-19 pandemic. But while many have continued operating, how have supply chains in the pharmaceutical market been impacted? How are organisations within this industry coping and what measure have they had to adopt in order to maintain ‘business as usual’?
Tony O’Sullivan, our Chief Commercial Officer, spoke with Pharmaceutical Manufacturing and Packing Sourcer (PMPS) to reveal his thoughts on the impact of Covid-19 and what we’ve been doing to ensure we continue to meet the demands of our customers.
For full article, click here
